Pfizer’s CEO tests positive for Covid-19 for the second time
Pfizer’s CEO tests positive for Covid-19 for the second time. Pfizer Inc (PFE.N) Chief Executive Officer Albert Borla said on Saturday that he has tested positive for COVID-19.
“I feel fine and am symptom-free,” Borla said in a statement.
Borla, 60, contracted COVID in August and started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid.
Paxlovid is an antiviral medicine used to treat people at high risk, such as elderly patients.
Borla has received four doses of a COVID vaccine developed by Pfizer and its German partner BioNTech ( 22UAy.DE ).
The chief executive said he had not yet received the new violent booster.
Read more: 22 more dengue cases reported in Islamabad
Developed by a team of Moderna and Pfizer and BioNTech, the new so-called bivalent shots are aimed at tackling the BA.5 and BA.4 Omicron subtypes, which make up 84.8% and 1.8% of all types circulating in the United States, respectively. are States, based on latest data.
Borla added, “I haven’t had a new bivalent booster yet, because I was following the CDC guidelines of waiting three months since my last COVID case back in mid-August. “
In August, the FDA approved updated booster shots from Pfizer and Moderna that target the dominant BA.4 and BA.5 Omicron subtypes.
A federal health agency said this week that more than 25 million doses of the so-called bivalent shots have been shipped. This included mostly Pfizer/BioNTech vaccines, as Moderna ramps up vaccine production.